Trial intelligence / Profile preview

Remimazolam versus propofol for elective general anesthesia in patients with hypertension

ChiCTR2000040579Phase 4Not yet recruiting

Sponsor
Fujian Medical University Union Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in hypertension (HTN) comparing Propofol arm with Remimazolam arm (2 arms). Primary endpoints: Blood pressure, Heart rate and 3 more. Planned start Nov 2020; status: not yet recruiting.

02

Drugs

remimazolampropofol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on ChiCTR2000040579.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040579.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call